{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:49:19Z","timestamp":1791139759838,"version":"4.1.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T00:00:00Z","timestamp":1266278400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0009239","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T16:00:33Z","timestamp":1266249633000},"page":"e9239","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":95,"title":["Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR"],"prefix":"10.1371","volume":"5","author":[{"given":"Ruhee","family":"Dere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Sandford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl Lyn","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,2,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.biocel.2004.03.012","article-title":"Polycystic kidney disease: new understanding in the pathogenesis.","volume":"36","author":"PD Wilson","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000112495","article-title":"Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment.","volume":"108","author":"MY Chang","year":"2008","journal-title":"Nephron Physiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1097\/01.ASN.0000028643.17901.42","article-title":"Genetics and pathogenesis of polycystic kidney disease.","volume":"13","author":"P Igarashi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.pathol.2.010506.091850","article-title":"Cystic disease of the kidney.","volume":"2","author":"PD Wilson","year":"2007","journal-title":"Annu Rev Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease.","volume":"369","author":"VE Torres","year":"2007","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(95)90339-9","article-title":"Polycystic kidney disease: the complete structure of the PKD1 gene and its protein.","volume":"81","author":"IPKD Consortium","year":"1995","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein.","volume":"272","author":"T Mochizuki","year":"1996","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1293-359","article-title":"Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease.","volume":"5","author":"DJ Peters","year":"1993","journal-title":"Nat Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"13035","DOI":"10.1021\/bi035074c","article-title":"Transmembrane domain analysis of polycystin-1, the product of the polycystic kidney disease-1 (PKD1) gene: evidence for 11 membrane-spanning domains.","volume":"42","author":"N Nims","year":"2003","journal-title":"Biochemistry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000093216","article-title":"The pathogenesis of autosomal dominant polycystic kidney disease.","volume":"103","author":"M Sutters","year":"2006","journal-title":"Nephron Exp Nephrol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/mlc.2003.13","article-title":"Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology.","volume":"141","author":"M Sutters","year":"2003","journal-title":"J Lab Clin Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0014-5793(03)00130-3","article-title":"Structure-function relationships of the extracellular domain of the autosomal dominant polycystic kidney disease-associated protein, polycystin-1.","volume":"538","author":"BS Weston","year":"2003","journal-title":"FEBS Lett"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/35050128","article-title":"Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.","volume":"408","author":"K Hanaoka","year":"2000","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/hmg\/9.11.1641","article-title":"Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1.","volume":"9","author":"O Ibraghimov-Beskrovnaya","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1097\/01.ASN.0000076075.49819.9B","article-title":"Functional analysis of PKD1 transgenic lines reveals a direct role for polycystin-1 in mediating cell-cell adhesion.","volume":"14","author":"AJ Streets","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref16","first-page":"1311","article-title":"The PKD1 gene product, \u201cpolycystin-1,\u201d is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia.","volume":"79","author":"PD Wilson","year":"1999","journal-title":"Lab Investig"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0070-2153(08)00606-6","article-title":"Chapter 6 mouse models of polycystic kidney disease.","volume":"84","author":"PD Wilson","year":"2008","journal-title":"Curr Top Dev Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1074\/jbc.274.8.4947","article-title":"The polycystic kidney disease 1 gene product modulates Wnt signaling.","volume":"274","author":"E Kim","year":"1999","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"27472","DOI":"10.1074\/jbc.M312183200","article-title":"Aberrant polycystin-1 expression results in modification of activator protein-1 activity, whereas Wnt signaling remains unaffected.","volume":"279","author":"NH Le","year":"2004","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1681\/ASN.2004110913","article-title":"Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.","volume":"16","author":"NH Le","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.devcel.2005.12.005","article-title":"Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease.","volume":"10","author":"SH Low","year":"2006","journal-title":"Dev Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.","volume":"103","author":"JM Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1097-2765(01)00226-X","article-title":"Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene.","volume":"7","author":"E Kleymenova","year":"2001","journal-title":"Mol Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.01259-08","article-title":"Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.","volume":"29","author":"G Distefano","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.","volume":"412","author":"J Huang","year":"2008","journal-title":"Biochem J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/hmg\/ddp032","article-title":"Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment.","volume":"18","author":"K Inoki","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1991.tb37742.x","article-title":"Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria.","volume":"615","author":"MR Gomez","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/hmg\/ddi260","article-title":"Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.","volume":"14","author":"DJ Kwiatkowski","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","article-title":"mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E.","volume":"24","author":"DC Fingar","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR.","volume":"18","author":"N Hay","year":"2004","journal-title":"Genes Dev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism.","volume":"124","author":"S Wullschleger","year":"2006","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/hmg\/ddp149","article-title":"Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.","volume":"18","author":"CS Bonnet","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/hmg\/ddn325","article-title":"The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.","volume":"18","author":"TR Hartman","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.","volume":"16","author":"Y Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).","volume":"21","author":"PR Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000104818","article-title":"Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease.","volume":"30","author":"M Wu","year":"2007","journal-title":"Kidney Blood Press Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease\u2013a contiguous gene syndrome.","volume":"8","author":"PT Brook-Carter","year":"1994","journal-title":"Nat Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1083\/jcb.200507119","article-title":"Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning.","volume":"173","author":"SL Cai","year":"2006","journal-title":"J Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1074\/jbc.273.11.6013","article-title":"The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.","volume":"273","author":"T Arnould","year":"1998","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/cs1040217","article-title":"The isolated C-terminus of polycystin-1 promotes increased ATP-stimulated chloride secretion in a collecting duct cell line.","volume":"104","author":"KM Hooper","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1093\/hmg\/ddn208","article-title":"Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling.","volume":"17","author":"M Lal","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"19566","DOI":"10.1074\/jbc.M201875200","article-title":"Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins.","volume":"277","author":"SC Parnell","year":"2002","journal-title":"J Biol Chem"},{"key":"ref43","article-title":"ATM Signals to TSC2 in the Cytoplasm to Regulate mTORC1 in Response to ROS. in press.","author":"A Alexander","year":"2010"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.","volume":"19","author":"G Benvenuto","year":"2000","journal-title":"Oncogene"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1440-1797.2007.00869.x","article-title":"Polycystic kidney disease and the renal cilium.","volume":"12","author":"JA Deane","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1681\/ASN.2006111215","article-title":"Role of primary cilia in the pathogenesis of polycystic kidney disease.","volume":"18","author":"BK Yoder","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/ndt\/gfn744","article-title":"Activation of the AKT\/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).","volume":"24","author":"DC Fischer","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"F1034","DOI":"10.1152\/ajprenal.00195.2003","article-title":"Murine models of polycystic kidney disease: molecular and therapeutic insights.","volume":"285","author":"LM Guay-Woodford","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2369-8-13","article-title":"Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study.","volume":"8","author":"AL Serra","year":"2007","journal-title":"BMC Nephrol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3949\/ccjm.76a.gr001","article-title":"Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments.","volume":"76","author":"WE Braun","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"ref51","first-page":"133","article-title":"Better understanding of ADPKD results in potential new treatment options: ready for the cure?","volume":"21","author":"E Meijer","year":"2008","journal-title":"J Nephrol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.","volume":"66","author":"KE O'Reilly","year":"2006","journal-title":"Cancer Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-8-38","article-title":"Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis.","volume":"8","author":"K Pollizzi","year":"2009","journal-title":"Mol Cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB.","volume":"22","author":"DD Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.","volume":"112","author":"H Zhang","year":"2003","journal-title":"J Clin Invest"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1002\/j.1460-2075.1992.tb05578.x","article-title":"Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells.","volume":"11","author":"SJ Neame","year":"1992","journal-title":"Embo J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0009239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:29:38Z","timestamp":1588958978000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0009239"}},"subtitle":[],"editor":[{"given":"Mikhail V.","family":"Blagosklonny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,2,16]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,2,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0009239","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,16]]}}}